Hexian Li
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 14
- CAR-T cell therapy research 12
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
- Co-authors
- Aiping Tong (19 shared papers)Ying Zhou (1 shared paper)Qizhong Lu (16 shared papers)Zongliang Zhang (17 shared papers)Meijun Zheng (8 shared papers)Kunhong Zhong (8 shared papers)Zeng Wang (4 shared papers)Guoqing Wang (5 shared papers)
- Journals
- Cancer Letters (2 papers)Journal of Nanobiotechnology (2 papers)Biomolecules (2 papers)Signal Transduction and Targeted Therapy (1 paper)The Structural Design of Tall and Special Buildings (1 paper)
- Partner nations
- ChinaNew ZealandUnited States
In The Last Decade
Hexian Li
21 papers receiving 522 citations
Hexian Li's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 232
- Immunology 113
- Genetics 101
- Biotechnology 28
- Genetics 29
Countries citing papers authored by Hexian Li
This map shows the geographic impact of Hexian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hexian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hexian Li more than expected).
Fields of papers citing papers by Hexian Li
This network shows the impact of papers produced by Hexian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hexian Li. The network helps show where Hexian Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hexian Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma Hit paper breakdown → | 2022 | 151 |
| 2 | 2013 | 65 | |
| 3 | 2021 | 63 | |
| 4 | 2020 | 47 | |
| 5 | 2024 | 29 | |
| 6 | 2024 | 16 | |
| 7 | 2023 | 15 | |
| 8 | 2024 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2024 | 13 | |
| 12 | 2024 | 13 | |
| 13 | 2024 | 13 | |
| 14 | 2024 | 12 | |
| 15 | 2023 | 10 | |
| 16 | 2021 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2022 | 7 | |
| 19 | 2025 | 5 | |
| 20 | 2023 | 4 |
About Hexian Li
Hexian Li is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Periodontics, having authored 24 papers that have together received 524 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (3 papers), T-cell and B-cell Immunology (2 papers), Dental Health and Care Utilization (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (232 citations), Immunology (113 citations), Genetics (101 citations), Biotechnology (28 citations) and Genetics (29 citations). Hexian Li has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Aiping Tong, Ying Zhou, Qizhong Lu, Zongliang Zhang, Meijun Zheng, Kunhong Zhong, Zeng Wang, Guoqing Wang, Xin Tang and Liangxue Zhou. Their work appears in journals such as Cancer Letters, Journal of Nanobiotechnology, Biomolecules, Signal Transduction and Targeted Therapy and The Structural Design of Tall and Special Buildings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.